Back to BAKER BROS. ADVISORS LP BAKER BROS. ADVISORS LP

ABCLABCL
Showing 8 of 23 quarters

Position history for BAKER BROS. ADVISORS LPBAKER BROS. ADVISORS LP's holdings in ABCELLERA BIOLOGICS INC

BAKER BROS. ADVISORS LP holds 33M shares of ABCL (ABCELLERA BIOLOGICS INC), worth $259.1M as of 2026-Q2. The position was increased (+9.0% shares). ABCL represents 1.3% of BAKER BROS. ADVISORS LP's portfolio.

Current Value

$259.1M

Current Shares

33M

Total Value Change

+$187.6M

Total Shares Change

+5.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
33M
+9.0%
$259.1M1.3%$7.85
53
2026-Q1
Increased
30.3M
+10.0%
$105.7M0.6%$3.71
47
2025-Q4
Unchanged
27.5M
0.0%
$94.1M0.6%$3.45
0
2025-Q3
Unchanged
27.5M
0.0%
$138.5M1.0%$4.87
0
2025-Q2
Unchanged
27.5M
0.0%
$94.4M0.9%$3.61
0
2025-Q1
Unchanged
27.5M
0.0%
$61.4M0.7%$2.31
0
2024-Q4
Unchanged
27.5M
0.0%
$80.7M0.9%$2.82
0
2024-Q3
Unchanged
27.5M
0.0%
$71.6M0.7%$2.61
0

Other major holders of ABCL: VIKING GLOBAL INVESTORS LP, Capital World Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used